¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"glomerular disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • prenatal disease
    Ãâ»ýÀüº´
  • primary cholestatic liver disease
    ¿ø¹ß¾µ°³ÁóÁ¤Ã¼°£Áúȯ, ¿ø¹ß´ãÁóÁ¤Ã¼°£Áúȯ
  • primary pigmented nodular adrenocortical disease
    ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½Å°ÑÁúº´, ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½ÅÇÇÁúº´
  • professional disease
    Àü¹®Á÷¾÷º´, Á÷¾÷º´
  • protozoan disease
    ¿øÃ溴
  • psychosomatic disease
    Á¤½Å½Åüº´
  • pulseless disease
    ¹«¸Æ¹Úº´
  • pyramidal disease
    ÇǶó¹Ìµå½Å°æ·Îº´, Ãßü·Îº´
  • Paget¡¯s disease
    ÆÄÁ¦Æ®º´
  • parasitic disease
    1. ±â»ýÃæº´ 2. ±â»ýÃæÁúȯ
  • Parkinson¡¯s disease
    ÆÄŲ½¼º´
  • paroxysmal disease
    ¹ßÀÛ¼ºÁúȯ
  • pelvic inflammatory disease
    °ñ¹Ý¿°ÁõÁúȯ, °ñ¹Ý¿°
  • pericardial disease
    ½ÉÀ帷º´, ½É³¶Áúȯ
  • periodontal disease
    Ä¡ÁÖº´, Ä¡ÁÖÁúȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • reversible obstructive lung disease
    °¡¿ªÆó¼âÆóº´
  • rheumatic disease
    ·ù¸¶Æ¼½ºº´
  • rheumatoid disease
    ·ù¸¶Æ¼½º¸ð¾çÁúȯ
  • rice disease
    (¢¡beriberi) °¢±â
  • rickettsial disease
    ¸®ÄÉÂ÷º´
  • rolling disease
    ÀüÀüº´
  • runt disease
    ¼Ò¸ðº´, ¿Ö¼Òº´
  • secondary disease
    ¼Ó¹ßº´
  • septic disease
    (¢¡sepsis) ÆÐÇ÷Áõ
  • sexually transmitted disease
    ¼ºº´, ¼º¸Å°³Áúȯ
  • sickle cell disease
    ³´ÀûÇ÷±¸º´, °â»óÀûÇ÷±¸º´
  • sleeping disease
    ¼ö¸éº´
  • slow disease
    Áö¹ßÁúȯ
  • specific disease
    ƯÀÌÁúȯ
  • spinal disease
    ô¼öº´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • aphthous fever =foot and mouth disease
    ¾ÆÇÁŸ¼º¿­(¡­æð).
  • apocrine miliaria => Fox Fordyce disease
    ¾ÆÆ÷Å©¸° ÇÑÁø
  • arbovirus disease
    ¾Æ¸£º¸¹ÙÀÌ·¯½ºº´(¡­Ü»)
  • arthropod-borne viral disease
    ÀýÁöµ¿¹° ¸Å°³ ¹ÙÀÌ·¯½ºº´
  • arthropod-borne viral disease
    ÀýÁöµ¿¹°¸Å°³¹ÙÀÌ·¯½º,¾Æº¸¹ÙÀÌ·¯½º
  • functional cardiovascular disease
    ±â´É¼º ½ÉÇ÷°üº´.
  • fungous disease
    Áø±ÕÁúȯ, °õÆÎÀÌÆò
  • gamma-chain disease
    °¨¸¶¼âº´, Gamma-chain º´
  • gastric vertigo =trousseau disease
    À§(¼º)Çö±â
  • gauchers disease
    °í½¦º´, Gaucher º´
  • generalized obstructive lung disease
    ¹ü¹ß¼º Æó¼â¼º ÆóÁúȯ(ÛñÛ¡àõøÍáð
  • gestational trophoblastic disease
    Àӽżº¿µ¾ç¸ð¼¼Æ÷Áúȯ(¡­ç½å×Ù½á¬øàòðü´)
  • glucose storage disease
    ´çÃàÀûÁúȯ.
  • glucuronidase deficiency disease
    ±Û·çÅ¥·Î´Ïµ¥À̽º °áÇÌÁõ
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀû Áúȯ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • diffuse interstitial pulmonary disease
    ¹Ì¸¸¼º °£Áú¼º ÆóÁúȯ
  • digestive tract disease
    ¼ÒÈ­°üÁúȯ.
  • digestive tract disease
    ¼ÒÈ­±â°èÅëÁúȯ.
  • digestive tract disease
    ¼ÒÈ­±â°èÅëÁúȯ.
  • disease
    º´(º´), Áúº´(Áúº´), Áúȯ(Áúȯ).
  • disease
    Áúº´(Ü»), Áúȯ(òðü´)
  • disease
    º´, Áúº´, Áúȯ
  • disease
    º´(Ü»), Áúº´(òðÜ»), Áúȯ(òðü´).
  • disease
    º´(ËÓ), Áúº´(̤ËÓ), Áúȯ(̷̤).
  • disease carrier
    º´¿ø(ü)º¸À¯ÀÚ(Ü»êÂô÷ÜÁêóíº).
  • disease carrier
    º´¿ø(ü)º¸À¯ÀÚ(ËÓËô̧ËÓËôËö).
  • disease control
    Áúº´°ü¸®.
  • disease detection
    Áúº´¹ß°ß.
  • disease entity
    Áúº´´ÜÀ§(òðܻӤêÈ).
  • disease entity
    Áúº´´ÜÀ§(̤ËÓËÀËô).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 18
NAD neutrophil actin dysfunction; new antigenic determinant; nicotinamide adenine dinucleotide; nicotini...
OD Doctor of Optometry; obtained absorbance; occipital dysplasia; occupational dermatitis; occupational...
OHD hydroxyvitamin D; Office of Human Development; Ondine-Hirschsprung disease; organic heart disease
PAIN pyoderma gangrenosum, aphthous stomatitis, inflammatory eye disease, erythema nodosum [disorders ass...
PAOD peripheral arterial occlusive disease; peripheral arteriosclerotic occlusive disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 18
COPD Chronic Obstructive Lung Disease
COPD Chronic Obstructive Pulmonary Disease
CRDQ Chronic Respiratory Disease Questionnaire
CRQ Chronic Respiratory Disease Questionnaire
CBD Chronic beryllium disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • thromboembolic disease
    Ç÷Àü »öÀü¼º Áúȯ
  • thyrotoxic heart disease
    °©»ó¼± Áßµ¶¼º ½ÉÀ庴
    °©»ó¼± ±â´É Ç×Áø°ú °ü·ÃÇÑ ½ÉÀå ÁúȯÀ¸·Î ½É¹æ ¼¼µ¿. ½ÉÀå È®´ë, ¿ïÇ÷¼º ½ÉºÎÀü µîÀÌ ³ªÅ¸³­´Ù.
  • tropical disease
    ¿­´ëº´
    °í¿Â ´Ù½ÀÇÏ°í ¹Ì°³¹ß Áö¿ªÀÌ ¸¹Àº ¿­´ë Áö¹æ¿¡¼­ ¸¹ÀÌ ¹ß»ýÇÏ´Â º´. ´ëÇ¥ÀûÀÎ °ÍÀ¸·Î´Â ¾Æ¸Þ¹Ù Àû¸®, Ä®¶ó¾ÆÀÚ¸£
  • tubulo-interstitial disease
    ¼¼´¢°ü-°£Áú¼º Áúȯ
  • ulceration in systemic disease
    Àü½Å ÁúȯÀÇ ±Ë¾çÈ­
  • unverrichts disease
    ¿îº£¸®È÷Æ® º´
    µ¿ÀǾî=myocolonus e
  • upper motor neuron disease
    »óºÎ ¿îµ¿ ´º·± Áúȯ
  • Urbach Wiethe disease
    ¿ì¹ÙÈåÀ§µ¥ º´
    À¯ÀüÀû ÁöÁú ´ë»ç ÀÌ»óÀ¸·Î, ÀÔ¼ú ³»¸é, Çô ¹Ø, ÀεÎ, ÈĵÎ, ±âŸ ¸¹Àº Àå¼Ò¿¡ À¯¸®Áú¾ç ÁöÁú-´çÁú È¥ÇÕ¹°ÀÇ È²»ö Ä§Âø¹°ÀÌ Æ¯Â¡ÀÌ´Ù. ¾ó±¼À̳ª »çÁö¿¡ °áÀý ±«¸¦ º¼ ¼ö ÀÖ´Ù. ±¤ °ú¹ÎÇüÀº Á¶Ç÷¼º ÇÁ·ÎÅäÆ÷¸£ÇǸ°ÁõÀÇ ÀÏÁ¾À̶ó°í »ý°¢µÈ´Ù.
  • vagabonds' disease
    ºÎ¶ûÀÚº´
  • valvular disease
    ÆÇ¸·º´, ÆÇ¸·º´
  • valvular disease of heart
    ½ÉÀåÆÇ¸·Áõ
  • valvular heart disease
    ÆÇ¸·¼º ½ÉÁúȯ
  • VDRL : Venereal Disease Research LaboratoryÀÇ ¾àÀÚ. ¸Åµ¶±ÕÀÇ Reagin¿¡ ´ëÇÑ Ç×ü·Î, ¸Åµ¶ÀÇ ¼±º°°Ë»ç·Î »ç¿ëµÇ¸ç ¸Åµ¶ Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀ ¿©ºÎ°¡ Ä¡·á È¿°ú ÆÇÁ¤¿¡ »ç¿ëµÈ´Ù. ¸Åµ¶ ¿Ü¿¡µµ Àü½Å¼º È«¹Ý¼º ³¶Ã¢(SLE), ·ù¸¶ÅäÀÌµå °üÀý¿° µî¿¡¼­µµ ¾ç¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
    VDRL ¸é»ó ¹ÝÀÀ
  • venereal disease control
    ¼ºº´ °ü¸®
  • viral respiratory disease
    ¹ÙÀÌ·¯½º È£Èí±â Áúȯ, ¹ÙÀÌ·¯½º¼º È£Èí±â Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
refsum disease A chronic progressive peripheral neuropathy which is probably inherited in an autosomal recessive manner. Some of the manifestations of this disorder are atypical retinitis pigmentosa, cerebellar ataxia, and increased cerebrospinal protein levels. Excessive phytanic acid storage has been found in most cases. Onset of symptoms usually occurs in early childhood. Infantile refsum disease (see peroxisomal disorders) differs in that it also includes mental retardation, dysmorphic features, peroxisomal deficiency, and very early onset.
(12 Dec 1998)
refsum's disease A genetic disorder of the fatty acid phytanic acid which accumulates and causes a number of progressive problems including polyneuritis (inflammation of numerous nerves), diminishing vision (due to retinitis pigmentosa), and wobbliness (ataxia) caused by damage to the cerebellar portion of the brain (cerebellar ataxia).
(12 Dec 1998)
Vincent's disease <disease> An acute or recurrent form of gingivitis of young to middle-aged adults characterised by red and painful gums, fetid breath and gum destruction. Other features may include fever and enlargement of the regional lymph nodes.
Pathogenesis of this condition is thought to be secondary to a fusiform bacillus and spirochetal (Treponema vincentii) microorganisms.
(14 Oct 1997)
McArdle disease <disease> Glycogen storage disease in which the defective enzyme is muscle phosphorylase.
(18 Nov 1997)
McArdle-Schmid-Pearson disease Glycogenosis due to muscle glycogen phosphorylase deficiency, resulting in accumulation of glycogen of normal chemical structure in muscle.
Synonym: McArdle's disease, McArdle's syndrome, McArdle-Schmid-Pearson disease, myophosphorylase deficiency glycogenosis.
(05 Mar 2000)
McArdle's disease Glycogenosis due to muscle glycogen phosphorylase deficiency, resulting in accumulation of glycogen of normal chemical structure in muscle.
Synonym: McArdle's disease, McArdle's syndrome, McArdle-Schmid-Pearson disease, myophosphorylase deficiency glycogenosis.
(05 Mar 2000)
Glanzmann's disease <haematology> A form of congenital platelet functional defect that result in prolongation of the bleeding time. Characteristics include mucosal and post-operative bleeding that may be severe.
(17 Dec 1997)
Glasser's disease <disease> A fibrinous polyserositis, polyarthritis, and meningitis of pigs caused by the bacterium Haemophilus parasuis.
(05 Mar 2000)
Virchow's disease A condition, either congenital or acquired, in which the head is abnormally large; usually applied to an adult skull with a capacity of over 1450 ml.
Synonym: leontiasis ossea, macrocephaly, macrocephalia, megacephalia, megalocephaly, megalocephalia, Virchow's disease.
Origin: mega-+ G. Kephale, head
(05 Mar 2000)
mechanobullous disease This represents a group of rare inherited disorders in which blistering of the skin occurs in response to skin trauma. Large fluid-filled blisters can occur in response to injury, skin rubbing, chafing or even increases in room temperature. Secondary bacterial infection of the blisters is common. Complications include oesophageal stricture, infections, loss of function of hands and feet and malnutrition. The dermatologist is the expert in the evaluation and treatment of this disorder.
(27 Sep 1997)
reiter's disease A triad of nongonococcal urethritis followed by conjunctivitis and arthritis, of unknown aetiology.
(12 Dec 1998)
virus X disease A term applied to a number of virus disease's of obscure aetiology, e.g., Australian X disease (Murray Valley encephalitis).
(05 Mar 2000)
visceral disease virus <virology> Probably the most widespread of the Herpetoviridae group.
Infected cells enlarge and have a characteristic inclusion body (composed of virus particles) in the nucleus. Causes disease only in utero (leading to abortion or stillbirth or to various congenital defects), although can be opportunistic in the immunocompromised host.
Patients who have been exposed to the virus will remain cytomegalovirus IgG positive.
Acronym: CMV
(30 Sep 1997)
Pauzat's disease Osteoplastic periostitis or fatigue fractures of the metatarsal bones, caused by excessive marching.
(05 Mar 2000)
Pavy's disease Cyclic or recurrent physiologic albuminuria.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 18
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 18
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 18
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 18
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 18
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 18
ÅëÇÕ°Ë»ö ¿Ï·á